Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients

Authors :: David Dalmau
Julio Sola
Juan Flores
Josep M. Llibre
Enric Pedrol
Jose Hernandez Quero
José Sanz
Jesús Sanz
Pepa Muñoz
Juan Gonzalez Lahoz
María José Galindo
Javier Torre de Lima
Josep M. Gatell
Consuelo Viladés
Daniel Podzamczer
Esperanza Antón
Pere Domingo
Eugenia Negredo
Hernando Knobel
Juan A. Pineda
Enrique Ortega
Montserrat Olmo
Lluís Force
Vicente Boix
Ana Mariño
Source :: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname
Publication Year :: 2009
Publisher :: LIPPINCOTT WILLIAMS & WILKINS, 2009.
Abstract: Background: The strategy of switching nevirapine (NVP) twice daily to once daily was evaluated. Methods: Forty-eight-week randomized, open, multicenter trial. Stable HIV-infected patients on NVP twice daily for > 12-18 weeks with alanine aminotransferase (ALT)

ISSN :: 15254135
Database :: OpenAIRE
Journal :: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname
Accession number :: edsair.doi.dedup.....33da11e636bc26f1f3f28f4d3c67347a

Tools